Terpenoid ID | TKC066631 | |
Chirality | TKC104159 | |
Cell line | 0 | |
Protein target | 14 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 9 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|---|---|---|---|---|---|---|
TKC066631 | COLO 205 | Colo 205; CoLo 205; COLO-205; Colo-205; COLO.205; Colo205; COLO205; Co 205; Colorado 205 | 14000.0 | nM | TGI | C4349 | |
TKC066631 | HCC 2998 | HCC-2998; HCC.2998; HCC 2998; Hamon Cancer Center 2998 | 12900.0 | nM | TGI | C4349 | |
TKC066631 | HCT-116 | HCT-116; HCT.116; HCT_116; HCT116; HCT116wt; CoCL2 | 13800.0 | nM | TGI | C4910 | |
TKC066631 | HCT-15 | HCT-15; HCT.15; HCT15 | 13900.0 | nM | TGI | C4349 | |
TKC066631 | HT-29 | HT 29; HT29 | 14300.0 | nM | TGI | C4349 | |
TKC066631 | KM12 | KM-12; KM.12 | 14200.0 | nM | TGI | C4910 | |
TKC066631 | SW-620 | SW-620; SW 620; SW.620 | 14400.0 | nM | TGI | C4349 | |
TKC066631 | Leukemia cells | 18500.0 | nM | TGI | |||
TKC066631 | NSCLC | NSCLCN6 | 13100.0 | nM | TGI | C3493 | |
TKC066631 | HEK293 | 14581.0 | nM | Potency |
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC066631 | Q16637 | Survival motor neuron protein | SMN1,SMN2 | 35481 | nM | Potency |
TKC066631 | Q16637 | Survival motor neuron protein | SMN1,SMN2 | 35481 | nM | Potency |
TKC066631 | P27695 | DNA-(apurinic or apyrimidinic site) endonuclease | APEX1 | 2239 | nM | Potency |
TKC066631 | O75496 | Geminin | GMNN | 7308 | nM | Potency |
TKC066631 | P00811 | Beta-lactamase | ampC | 25119 | nM | Potency |
TKC066631 | Q96QE3 | ATPase family AAA domain-containing protein 5 | ATAD5 | 16360 | nM | Potency |
TKC066631 | Q6W5P4 | Neuropeptide S receptor | NPSR1 | 12589 | nM | Potency |
TKC066631 | P25779 | Cruzipain | 3162 | nM | Potency | |
TKC066631 | Q9F4F7 | 4'-phosphopantetheinyl transferase ffp | ffp | 4467 | nM | Potency |
TKC066631 | Q9NR56 | Muscleblind-like protein 1 | MBNL1 | 100 | nM | Potency |
TKC066631 | P51450 | Nuclear receptor ROR-gamma | Rorc | 891 | nM | Potency |
TKC066631 | P02545 | Prelamin-A/C | LMNA | 17783 | nM | Potency |
TKC066631 | P42858 | Huntingtin | HTT | 35481 | nM | Potency |
TKC066631 | P17861 | X-box-binding protein 1 | XBP1 | 9470 | nM | IC50 |
TKC066631 | P35639 | DNA damage-inducible transcript 3 protein | Ddit3 | >5960 | nM | IC50 |
TKC066631 | P35639 | DNA damage-inducible transcript 3 protein | Ddit3 | >10000 | nM | IC50 |
TKC066631 | O43521 | Bcl-2-like protein 11 | BCL2L11 | 65530 | nM | EC50 |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
Q16637 | SMN_HUMAN | Muscular atrophy [ICD-11: 8B61] |
Q16637 | SMN_HUMAN | Muscular atrophy [ICD-11: 8B61] |
Q16637 | SMN_HUMAN | Muscular atrophy [ICD-11: 8B61] |
Q16637 | SMN_HUMAN | Muscular atrophy [ICD-11: 8B61] |
P27695 | APEX1_HUMAN | Retinopathy [ICD-11: 9B71] |
P27695 | APEX1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P27695 | APEX1_HUMAN | Ocular cancer [ICD-11: 2D00-2D07] |
P27695 | APEX1_HUMAN | Brain cancer [ICD-11: 2A00] |
P27695 | APEX1_HUMAN | Melanoma [ICD-11: 2C30] |
P25779 | CYSP_TRYCR | Parasitic worm infestation [ICD-11: 1F90] |
P25779 | CYSP_TRYCR | Malaria [ICD-11: 1F40-1F45] |
P42858 | HD_HUMAN | Choreiform disorder [ICD-11: 8A01] |